Zura Bio (ZURA) Competitors $1.22 +0.03 (+2.52%) Closing price 04:00 PM EasternExtended Trading$1.22 0.00 (-0.41%) As of 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ZURA vs. RAPP, PHAT, MBX, RGNX, TKNO, BNTC, ANNX, TERN, PROK, and DSGNShould you be buying Zura Bio stock or one of its competitors? The main competitors of Zura Bio include Rapport Therapeutics (RAPP), Phathom Pharmaceuticals (PHAT), MBX Biosciences (MBX), REGENXBIO (RGNX), Alpha Teknova (TKNO), Benitec Biopharma (BNTC), Annexon (ANNX), Terns Pharmaceuticals (TERN), ProKidney (PROK), and Design Therapeutics (DSGN). These companies are all part of the "pharmaceutical products" industry. Zura Bio vs. Rapport Therapeutics Phathom Pharmaceuticals MBX Biosciences REGENXBIO Alpha Teknova Benitec Biopharma Annexon Terns Pharmaceuticals ProKidney Design Therapeutics Zura Bio (NASDAQ:ZURA) and Rapport Therapeutics (NASDAQ:RAPP) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, media sentiment, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk. Does the MarketBeat Community believe in ZURA or RAPP? Zura Bio received 17 more outperform votes than Rapport Therapeutics when rated by MarketBeat users. However, 100.00% of users gave Rapport Therapeutics an outperform vote while only 79.17% of users gave Zura Bio an outperform vote. CompanyUnderperformOutperformZura BioOutperform Votes1979.17% Underperform Votes520.83% Rapport TherapeuticsOutperform Votes2100.00% Underperform VotesNo Votes Do insiders & institutionals hold more shares of ZURA or RAPP? 61.1% of Zura Bio shares are held by institutional investors. 22.1% of Zura Bio shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Do analysts rate ZURA or RAPP? Zura Bio presently has a consensus price target of $15.80, suggesting a potential upside of 1,195.08%. Rapport Therapeutics has a consensus price target of $35.00, suggesting a potential upside of 290.63%. Given Zura Bio's higher probable upside, equities research analysts plainly believe Zura Bio is more favorable than Rapport Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zura Bio 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.00Rapport Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is ZURA or RAPP more profitable? Rapport Therapeutics' return on equity of 0.00% beat Zura Bio's return on equity.Company Net Margins Return on Equity Return on Assets Zura BioN/A -37.36% -29.81% Rapport Therapeutics N/A N/A N/A Which has preferable earnings and valuation, ZURA or RAPP? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZura BioN/AN/A-$69.24MN/AN/ARapport TherapeuticsN/AN/A-$34.79MN/AN/A Does the media refer more to ZURA or RAPP? In the previous week, Rapport Therapeutics had 2 more articles in the media than Zura Bio. MarketBeat recorded 5 mentions for Rapport Therapeutics and 3 mentions for Zura Bio. Zura Bio's average media sentiment score of 0.59 beat Rapport Therapeutics' score of -0.12 indicating that Zura Bio is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zura Bio 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Rapport Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryZura Bio beats Rapport Therapeutics on 7 of the 12 factors compared between the two stocks. Remove Ads Get Zura Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ZURA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZURA vs. The Competition Export to ExcelMetricZura BioBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$79.66M$3.07B$5.66B$7.98BDividend YieldN/A1.47%4.89%4.03%P/E RatioN/A28.0823.8618.90Price / SalesN/A364.80382.33118.44Price / CashN/A168.6838.0534.62Price / Book0.663.416.844.18Net Income-$69.24M-$71.72M$3.19B$246.59M7 Day Performance6.09%-1.57%-0.48%-1.69%1 Month Performance-13.48%-9.54%-6.62%-8.83%1 Year Performance-62.23%-24.69%8.73%0.01% Zura Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZURAZura Bio1.9387 of 5 stars$1.22+2.5%$15.80+1,195.1%-63.3%$79.66MN/A0.003News CoverageRAPPRapport Therapeutics1.5257 of 5 stars$8.27-3.7%$35.00+323.2%N/A$302.48MN/A0.00N/ANews CoverageGap DownHigh Trading VolumePHATPhathom Pharmaceuticals3.5926 of 5 stars$4.40-13.0%$22.17+403.8%-50.5%$300.86M$55.25M-0.77110Analyst ForecastNews CoverageMBXMBX Biosciences2.2076 of 5 stars$8.98-9.2%$37.25+314.8%N/A$300.09MN/A0.0036Lockup ExpirationGap DownRGNXREGENXBIO4.1311 of 5 stars$6.01-5.2%$33.88+463.6%-73.6%$297.77M$84.33M-1.19370TKNOAlpha Teknova1.9218 of 5 stars$5.52-9.4%$8.50+54.0%+93.7%$294.26M$37.75M-7.46240Earnings ReportBNTCBenitec Biopharma2.5525 of 5 stars$12.27-5.5%$24.43+99.1%+150.9%$287.74M$80,000.00-8.1320Positive NewsGap UpANNXAnnexon2.0356 of 5 stars$2.61-5.4%$15.80+505.4%-47.5%$286.34MN/A-2.4960TERNTerns Pharmaceuticals4.3724 of 5 stars$3.36-3.7%$18.30+444.6%-58.6%$285.40MN/A-2.8540Upcoming EarningsPROKProKidney1.5348 of 5 stars$0.98-7.0%$5.00+412.0%-41.3%$284.84MN/A-1.783DSGNDesign Therapeutics1.7492 of 5 stars$4.87-1.0%$7.00+43.7%+69.1%$275.74MN/A-5.7340Earnings ReportUpcoming EarningsNews Coverage Remove Ads Related Companies and Tools Related Companies RAPP Alternatives PHAT Alternatives MBX Alternatives RGNX Alternatives TKNO Alternatives BNTC Alternatives ANNX Alternatives TERN Alternatives PROK Alternatives DSGN Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ZURA) was last updated on 3/11/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zura Bio Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Zura Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZURA Stock Alerts